Медицинская иммунология (Jul 2014)

СLINICAL EFFICIENCY OF STATINS IN RHEUMATOID ARTHRITIS: A PILOT STUDY

  • I. V. Shirinsky,
  • O. I. Zheltova,
  • N. Yu. Solovieva,
  • V. S. Shirinsky,
  • V. A. Kozlov

DOI
https://doi.org/10.15789/1563-0625-2007-4-5-505-508
Journal volume & issue
Vol. 9, no. 4-5
pp. 505 – 508

Abstract

Read online

Abstract. Statins are widely used to lower lipid levels and prevent cardiovascular disease. Recently described anti-inflammatory and immunomodulating properties of statins substantiate their application as a potentially novel treatment for autoimmune diseases. We evaluated efficacy and safety of simvastatin (40 mg daily) in patients with active rheumatoid arthritis (RA), as a supplement to stable doses of disease-modifying antirheumatic drugs. After 12 weeks of treatment, there was registered a significant decrease in disease activity score (by 0.89 points), improvement of life quality, and attenuation of pain levels. To confirm efficacy and safety of simvastatin in active RA, a large-scale controlled randomized study should be performed.

Keywords